Download PDF
Semin Respir Crit Care Med 2020; 41(06): 862-873
DOI: 10.1055/s-0040-1714250
Review Article

Chronic Obstructive Pulmonary Disease and Lung Transplantation

Mark Greer
1   Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany
2   Biomedical Research in End-Stage and Obstructive Lung Disease (BREATH), German Centre for Lung Research (DZL), Hannover, Germany
,
Tobias Welte
1   Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany
2   Biomedical Research in End-Stage and Obstructive Lung Disease (BREATH), German Centre for Lung Research (DZL), Hannover, Germany
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Lung transplantation (LTx) has been a viable option for patients with end-stage chronic obstructive pulmonary disease (COPD), with more than 20,000 procedures performed worldwide. Survival after LTx lags behind most other forms of solid-organ transplantation, with median survival for COPD recipients being a sobering 6.0 years. Given the limited supply of suitable donor organs, not all patients with end-stage COPD are candidates for LTx. We discuss appropriate criteria for accepting patients for LTx, as well as contraindications and exclusionary criteria. In the first year post-LTx, infection and graft failure are the leading causes of death. Beyond this chronic graft rejection—currently referred to as chronic lung allograft dysfunction—represents the leading cause of death at all time points, with infection and over time malignancy also limiting survival. Referral of COPD patients to a lung transplant center should be considered in the presence of progressing disease despite maximal medical therapy. As a rule of thumb, a forced expiratory volume in 1 second < 25% predicted in the absence of exacerbation, hypoxia (PaO2 < 60 mm Hg/8 kPa), and/or hypercapnia (PaCO2 > 50 mm Hg/6.6 kPa) and satisfactory general clinical condition should be considered the basic prerequisites for timely referral. We also discuss salient issues post-LTx and factors that impact posttransplant survival and morbidity such as infections, malignancy, renal insufficiency, and complications associated with long-term immunosuppression.

Keywords

chronic obstructive lung disease - COPD - emphysema - lung transplantation - lung volume reduction surgery


Publication History

Article published online:
29 July 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.

 

  • References

  • 1 Chambers DC, Cherikh WS, Harhay MO. et al; International Society for Heart and Lung Transplantation. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; focus theme: donor and recipient size match. J Heart Lung Transplant 2019; 38 (10) 1042-1055
    CrossrefPubMedGoogle Scholar
  • 2 Verleden GM, Glanville AR, Lease ED. et al. Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment - a consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant 2019; 38 (05) 493-503
    CrossrefPubMedGoogle Scholar
  • 3 Sato M, Ohmori-Matsuda K, Saito T. et al. Time-dependent changes in the risk of death in pure bronchiolitis obliterans syndrome (BOS). J Heart Lung Transplant 2013; 32 (05) 484-491
    CrossrefPubMedGoogle Scholar
  • 4 Fishman A, Martinez F, Naunheim K. et al; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348 (21) 2059-2073
    CrossrefPubMedGoogle Scholar
  • 5 Sood A, Petersen H, Qualls C. et al. Spirometric variability in smokers: transitions in COPD diagnosis in a five-year longitudinal study. Respir Res 2016; 17 (01) 147
    CrossrefPubMedGoogle Scholar
  • 6 Fortis S, Comellas A, Make BJ. et al. Combined forced expiratory volume in 1 second and forced vital capacity bronchodilator response, exacerbations, and mortality in chronic obstructive pulmonary disease. Ann Am Thorac Soc 2019; 16 (07) 826-835
    CrossrefPubMedGoogle Scholar
  • 7 Boutou AK, Shrikrishna D, Tanner RJ. et al. Lung function indices for predicting mortality in COPD. Eur Respir J 2013; 42 (03) 616-625
    CrossrefPubMedGoogle Scholar
  • 8 Hartl S, Lopez-Campos JL, Pozo-Rodriguez F. et al. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J 2016; 47 (01) 113-121
    CrossrefPubMedGoogle Scholar
  • 9 Cote CG, Pinto-Plata VM, Marin JM, Nekach H, Dordelly LJ, Celli BR. The modified BODE index: validation with mortality in COPD. Eur Respir J 2008; 32 (05) 1269-1274
    CrossrefPubMedGoogle Scholar
  • 10 Pirard L, Marchand E. Reassessing the BODE score as a criterion for listing COPD patients for lung transplantation. Int J Chron Obstruct Pulmon Dis 2018; 13: 3963-3970
    CrossrefPubMedGoogle Scholar
  • 11 Reed RM, Cabral HJ, Dransfield MT. et al. Survival of lung transplant candidates with COPD: BODE score reconsidered. Chest 2018; 153 (03) 697-701
    CrossrefPubMedGoogle Scholar
  • 12 Charman SC, Sharples LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 2002; 21 (02) 226-232
    CrossrefPubMedGoogle Scholar
  • 13 De Meester J, Smits JM, Persijn GG, Haverich A. Listing for lung transplantation: life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 2001; 20 (05) 518-524
    CrossrefPubMedGoogle Scholar
  • 14 Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351 (9095): 24-27
    CrossrefPubMedGoogle Scholar
  • 15 Stavem K, Bjørtuft Ø, Borgan Ø, Geiran O, Boe J. Lung transplantation in patients with chronic obstructive pulmonary disease in a national cohort is without obvious survival benefit. J Heart Lung Transplant 2006; 25 (01) 75-84
    CrossrefPubMedGoogle Scholar
  • 16 Siddiqui FM, Diamond JM. Lung transplantation for chronic obstructive pulmonary disease: past, present, and future directions. Curr Opin Pulm Med 2018; 24 (02) 199-204
    CrossrefPubMedGoogle Scholar
  • 17 Thabut G, Ravaud P, Christie JD. et al. Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177 (10) 1156-1163
    CrossrefPubMedGoogle Scholar
  • 18 Todd JL, Palmer SM. Lung transplantation in advanced COPD: is it worth it?. Semin Respir Crit Care Med 2010; 31 (03) 365-372
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Patel N, DeCamp M, Criner GJ. Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5 (04) 447-453
    CrossrefPubMedGoogle Scholar
  • 20 Rodrigue JR, Baz MA, Kanasky Jr WF, MacNaughton KL. Does lung transplantation improve health-related quality of life? The University of Florida experience. J Heart Lung Transplant 2005; 24 (06) 755-763
    CrossrefPubMedGoogle Scholar
  • 21 Kugler C, Fischer S, Gottlieb J. et al. Health-related quality of life in two hundred-eighty lung transplant recipients. J Heart Lung Transplant 2005; 24 (12) 2262-2268
    CrossrefPubMedGoogle Scholar
  • 22 Snyder LD, Palmer SM. Quality, quantity, or both? Life after lung transplantation. Chest 2005; 128 (03) 1086-1087
    CrossrefPubMedGoogle Scholar
  • 23 Weill D, Benden C, Corris PA. et al. A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2015; 34 (01) 1-15
    CrossrefPubMedGoogle Scholar
  • 24 Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol 2009; 169 (02) 236-248
    CrossrefPubMedGoogle Scholar
  • 25 Vos R, De Vusser K, Schaevers V. et al. Smoking resumption after lung transplantation: a sobering truth. Eur Respir J 2010; 35 (06) 1411-1413
    CrossrefPubMedGoogle Scholar
  • 26 Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J 2009; 33 (05) 1165-1185
    CrossrefPubMedGoogle Scholar
  • 27 Vanfleteren LE, Spruit MA, Groenen M. et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187 (07) 728-735
    CrossrefPubMedGoogle Scholar
  • 28 Adjei Boakye E, Wang M, Sharma A. et al. Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers. J Cancer Res Clin Oncol 2020; 146 (07) 1765-1779
    CrossrefPubMedGoogle Scholar
  • 29 Almagro P, Boixeda R, Diez-Manglano J, Gómez-Antúnez M, López-García F, Recio J. Insights into chronic obstructive pulmonary disease as critical risk factor for cardiovascular disease. Int J Chron Obstruct Pulmon Dis 2020; 15: 755-764
    CrossrefPubMedGoogle Scholar
  • 30 Almagro P, Cabrera FJ, Diez J. et al; Working Group on, COPD, Spanish Society of Internal Medicine. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de Medicina Interna (ESMI) study. Chest 2012; 142 (05) 1126-1133
    CrossrefPubMedGoogle Scholar
  • 31 Halloran K, Hirji A, Li D. et al. Coronary artery disease and coronary artery bypass grafting at the time of lung transplantation do not impact overall survival. Transplantation 2019; 103 (10) 2190-2195
    CrossrefPubMedGoogle Scholar
  • 32 Hachem RR, Yusen RD, Chakinala MM. et al. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. J Heart Lung Transplant 2007; 26 (10) 1012-1018
    CrossrefPubMedGoogle Scholar
  • 33 Sikma MA, van Maarseveen EM, van de Graaf EA. et al. Pharmacokinetics and toxicity of tacrolimus early after heart and lung transplantation. Am J Transplant 2015; 15 (09) 2301-2313
    CrossrefPubMedGoogle Scholar
  • 34 van Kessel DA, Hoffman TW, Kwakkel-van Erp JM. et al. Long-term follow-up of humoral immune status in adult lung transplant recipients. Transplantation 2017; 101 (10) 2477-2483
    CrossrefPubMedGoogle Scholar
  • 35 Freer G, Pistello M. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies. New Microbiol 2018; 41 (02) 95-105
    PubMedGoogle Scholar
  • 36 Sciurba FC, Criner GJ, Strange C. et al; RENEW Study Research Group. Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW Randomized Clinical Trial. JAMA 2016; 315 (20) 2178-2189
    CrossrefPubMedGoogle Scholar
  • 37 Slebos DJ, Shah PL, Herth FJ, Valipour A. Endobronchial valves for endoscopic lung volume reduction: best practice recommendations from Expert Panel on Endoscopic Lung Volume Reduction. Respiration 2017; 93 (02) 138-150
    CrossrefPubMedGoogle Scholar
  • 38 Burns KE, Keenan RJ, Grgurich WF, Manzetti JD, Zenati MA. Outcomes of lung volume reduction surgery followed by lung transplantation: a matched cohort study. Ann Thorac Surg 2002; 73 (05) 1587-1593
    CrossrefPubMedGoogle Scholar
  • 39 Fuehner T, Clajus C, Fuge J. et al. Lung transplantation after endoscopic lung volume reduction. Respiration 2015; 90 (03) 243-250
    CrossrefPubMedGoogle Scholar
  • 40 Destors M, Aniwidyaningsih W, Jankowski A, Pison C. Endoscopic volume reduction before or after lung transplantation. Eur J Cardiothorac Surg 2012; 42 (05) 897-898
    CrossrefPubMedGoogle Scholar
  • 41 Backhus L, Sargent J, Cheng A, Zeliadt S, Wood D, Mulligan M. Outcomes in lung transplantation after previous lung volume reduction surgery in a contemporary cohort. J Thorac Cardiovasc Surg 2014; 147 (05) 1678-1683.e1
    CrossrefPubMedGoogle Scholar
  • 42 Shigemura N, Gilbert S, Bhama JK. et al. Lung transplantation after lung volume reduction surgery. Transplantation 2013; 96 (04) 421-425
    CrossrefPubMedGoogle Scholar
  • 43 Galiè N, Humbert M, Vachiery JL. et al; ESC Scientific Document Group. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37 (01) 67-119
    CrossrefPubMedGoogle Scholar
  • 44 Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; 131 (04) 493-498
    CrossrefPubMedGoogle Scholar
  • 45 Barberà JA, Roger N, Roca J, Rovira I, Higenbottam TW, Rodriguez-Roisin R. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet 1996; 347 (8999): 436-440
    CrossrefPubMedGoogle Scholar
  • 46 Hurdman J, Condliffe R, Elliot CA. et al. Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J 2013; 41 (06) 1292-1301
    CrossrefPubMedGoogle Scholar
  • 47 Hayes Jr D, Black SM, Tobias JD, Mansour HM, Whitson BA. Prevalence of pulmonary hypertension and its influence on survival in patients with advanced chronic obstructive pulmonary disease prior to lung transplantation. COPD 2016; 13 (01) 50-56
    CrossrefPubMedGoogle Scholar
  • 48 Lahzami S, Bridevaux PO, Soccal PM. et al. Survival impact of lung transplantation for COPD. Eur Respir J 2010; 36 (01) 74-80
    CrossrefPubMedGoogle Scholar
  • 49 Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60 (11) 925-931
    CrossrefPubMedGoogle Scholar
  • 50 Holm AM, Immer F, Benden C. Lung allocation for transplant: the European perspective. Clin Transplant 2020; e13883
    PubMedGoogle Scholar
  • 51 Egan TM, Murray S, Bustami RT. et al. Development of the new lung allocation system in the United States. Am J Transplant 2006; 6 (5, Pt 2): 1212-1227
    CrossrefPubMedGoogle Scholar
  • 52 Egan TM, Edwards LB. Effect of the lung allocation score on lung transplantation in the United States. J Heart Lung Transplant 2016; 35 (04) 433-439
    CrossrefPubMedGoogle Scholar
  • 53 Gottlieb J, Greer M, Sommerwerck U. et al. Introduction of the lung allocation score in Germany. Am J Transplant 2014; 14 (06) 1318-1327
    CrossrefPubMedGoogle Scholar
  • 54 Valapour M, Lehr CJ, Skeans MA. et al. OPTN/SRTR 2018 annual data report: lung. Am J Transplant 2020; 20 (Suppl. 01) 427-508
    CrossrefPubMedGoogle Scholar
  • 55 Gottlieb J, Warnecke G, Hadem J. et al. Outcome of critically ill lung transplant candidates on invasive respiratory support. Intensive Care Med 2012; 38 (06) 968-975
    CrossrefPubMedGoogle Scholar
  • 56 Singer JP, Blanc PD, Hoopes C. et al. The impact of pretransplant mechanical ventilation on short- and long-term survival after lung transplantation. Am J Transplant 2011; 11 (10) 2197-2204
    CrossrefPubMedGoogle Scholar
  • 57 Hämmäinen P, Schersten H, Lemström K. et al. Usefulness of extracorporeal membrane oxygenation as a bridge to lung transplantation: a descriptive study. J Heart Lung Transplant 2011; 30 (01) 103-107
    CrossrefPubMedGoogle Scholar
  • 58 Vermeijden JW, Zijlstra JG, Erasmus ME, van der Bij W, Verschuuren EA. Lung transplantation for ventilator-dependent respiratory failure. J Heart Lung Transplant 2009; 28 (04) 347-351
    CrossrefPubMedGoogle Scholar
  • 59 Sharma NS, Hartwig MG, Hayes Jr D. Extracorporeal membrane oxygenation in the pre and post lung transplant period. Ann Transl Med 2017; 5 (04) 74
    CrossrefPubMedGoogle Scholar
  • 60 Mason DP, Thuita L, Nowicki ER, Murthy SC, Pettersson GB, Blackstone EH. Should lung transplantation be performed for patients on mechanical respiratory support? The US experience. J Thorac Cardiovasc Surg 2010; 139 (03) 765-773.e1
    CrossrefPubMedGoogle Scholar
  • 61 Hayanga AJ, Du AL, Joubert K. et al. Mechanical ventilation and extracorporeal membrane oxygenation as a bridging strategy to lung transplantation: significant gains in survival. Am J Transplant 2018; 18 (01) 125-135
    CrossrefPubMedGoogle Scholar
  • 62 Hayes Jr D, Tobias JD, Tumin D. Center volume and extracorporeal membrane oxygenation support at lung transplantation in the lung allocation score era. Am J Respir Crit Care Med 2016; 194 (03) 317-326
    CrossrefPubMedGoogle Scholar
  • 63 Hayanga AJ, Aboagye J, Esper S. et al. Extracorporeal membrane oxygenation as a bridge to lung transplantation in the United States: an evolving strategy in the management of rapidly advancing pulmonary disease. J Thorac Cardiovasc Surg 2015; 149 (01) 291-296
    CrossrefPubMedGoogle Scholar
  • 64 Fuehner T, Kuehn C, Hadem J. et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 2012; 185 (07) 763-768
    CrossrefPubMedGoogle Scholar
  • 65 Olsson KM, Simon A, Strueber M. et al. Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant 2010; 10 (09) 2173-2178
    CrossrefPubMedGoogle Scholar
  • 66 Chiumello D, Coppola S, Froio S, Colombo A, Del Sorbo L. Extracorporeal life support as bridge to lung transplantation: a systematic review. Crit Care 2015; 19: 19
    CrossrefPubMedGoogle Scholar
  • 67 Hayes Jr D, Tumin D, Budev MM, Tobias JD, St John RC, Kukreja J. Adverse outcomes associated with pulmonary hypertension in chronic obstructive pulmonary disease after bilateral lung transplantation. Respir Med 2017; 128: 102-108
    CrossrefPubMedGoogle Scholar
  • 68 Nasir BS, Mulvihill MS, Barac YD. et al. Single lung transplantation in patients with severe secondary pulmonary hypertension. J Heart Lung Transplant 2019; 38 (09) 939-948
    CrossrefPubMedGoogle Scholar
  • 69 Pochettino A, Kotloff RM, Rosengard BR. et al. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease: intermediate-term results. Ann Thorac Surg 2000; 70 (06) 1813-1818 , discussion 1818–1819
    CrossrefPubMedGoogle Scholar
  • 70 Bavaria JE, Kotloff R, Palevsky H. et al. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg 1997; 113 (03) 520-527 , discussion 528
    CrossrefPubMedGoogle Scholar
  • 71 Sundaresan RS, Shiraishi Y, Trulock EP. et al. Single or bilateral lung transplantation for emphysema?. J Thorac Cardiovasc Surg 1996; 112 (06) 1485-1494 , discussion 1494–1495
    CrossrefPubMedGoogle Scholar
  • 72 Thabut G, Christie JD, Ravaud P. et al. Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet 2008; 371 (9614): 744-751
    CrossrefPubMedGoogle Scholar
  • 73 Schaffer JM, Singh SK, Reitz BA, Zamanian RT, Mallidi HR. Single- vs double-lung transplantation in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis since the implementation of lung allocation based on medical need. JAMA 2015; 313 (09) 936-948
    CrossrefPubMedGoogle Scholar
  • 74 Anderson MR, Tabah A, RoyChoudhury A, Lederer DJ. Procedure preference and intention-to-treat outcomes after listing for lung transplantation among U.S. adults. A cohort study. Ann Am Thorac Soc 2019; 16 (02) 231-239
    CrossrefPubMedGoogle Scholar
  • 75 Crawford TC, Lui C, Magruder JT. et al. Five-year mortality hazard is reduced in chronic obstructive pulmonary disease patients receiving double- versus single-lung transplants. J Surg Res 2019; 237: 118-125
    CrossrefPubMedGoogle Scholar
  • 76 Weill D, Torres F, Hodges TN, Olmos JJ, Zamora MR. Acute native lung hyperinflation is not associated with poor outcomes after single lung transplant for emphysema. J Heart Lung Transplant 1999; 18 (11) 1080-1087
    CrossrefPubMedGoogle Scholar
  • 77 Yonan NA, el-Gamel A, Egan J, Kakadellis J, Rahman A, Deiraniya AK. Single lung transplantation for emphysema: predictors for native lung hyperinflation. J Heart Lung Transplant 1998; 17 (02) 192-201
    PubMedGoogle Scholar
  • 78 de Miguel-Díez J, López-de-Andres A, Hernández-Barrera V, de Miguel-Yanes JM, Méndez-Bailón M, Jiménez-García R. Trends and hospital outcomes of lung transplantation among patients with and without chronic obstructive pulmonary disease in Spain: a national population-based study (2001-2015). Int J Chron Obstruct Pulmon Dis 2019; 14: 729-737
    CrossrefPubMedGoogle Scholar
  • 79 Beer A, Reed RM, Bölükbas S. et al. Mechanical ventilation after lung transplantation. An international survey of practices and preferences. Ann Am Thorac Soc 2014; 11 (04) 546-553
    CrossrefPubMedGoogle Scholar
  • 80 Verbeek GL, Myles PS. Intraoperative protective ventilation strategies in lung transplantation. Transplant Rev (Orlando) 2013; 27 (01) 30-35
    CrossrefPubMedGoogle Scholar
  • 81 Felten ML, Moyer JD, Dreyfus JF. et al; Foch Lung Transplant Group. Immediate postoperative extubation in bilateral lung transplantation: predictive factors and outcomes. Br J Anaesth 2016; 116 (06) 847-854
    CrossrefPubMedGoogle Scholar
  • 82 Pilarczyk K, Carstens H, Heckmann J. et al. Safety and efficiency of percutaneous dilatational tracheostomy with direct bronchoscopic guidance for thoracic transplant recipients. Respir Care 2016; 61 (02) 235-242
    CrossrefPubMedGoogle Scholar
  • 83 Hadem J, Gottlieb J, Seifert D. et al. Prolonged mechanical ventilation after lung transplantation-a single-center study. Am J Transplant 2016; 16 (05) 1579-1587
    CrossrefPubMedGoogle Scholar
  • 84 Snell GI, Yusen RD, Weill D. et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction, part I: Definition and grading-A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2017; 36 (10) 1097-1103
    CrossrefPubMedGoogle Scholar
  • 85 Christie JD, Kotloff RM, Ahya VN. et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005; 171 (11) 1312-1316
    CrossrefPubMedGoogle Scholar
  • 86 Diamond JM, Lee JC, Kawut SM. et al; Lung Transplant Outcomes Group. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013; 187 (05) 527-534
    CrossrefPubMedGoogle Scholar
  • 87 Prekker ME, Nath DS, Walker AR. et al. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation. J Heart Lung Transplant 2006; 25 (04) 371-378
    CrossrefPubMedGoogle Scholar
  • 88 Mazo C, Borgatta B, Pont T. et al. Procalcitonin accurately predicts lung transplant adults with low risk of pulmonary graft dysfunction and intensive care mortality. J Crit Care 2018; 44: 142-147
    CrossrefPubMedGoogle Scholar
  • 89 Riera J, Senna A, Cubero M, Roman A, Rello J. Vall d'Hebron Lung Transplant Study Group Investigators. Primary graft dysfunction and mortality following lung transplantation: a role for proadrenomedullin plasma levels. Am J Transplant 2016; 16 (02) 634-639
    CrossrefPubMedGoogle Scholar
  • 90 Feltracco P, Serra E, Barbieri S. et al. Noninvasive ventilation in postoperative care of lung transplant recipients. Transplant Proc 2009; 41 (04) 1339-1344
    CrossrefPubMedGoogle Scholar
  • 91 Feltracco P, Milevoj M, Alberti V. et al. Early tracheostomy following lung transplantation. Transplant Proc 2011; 43 (04) 1151-1155
    CrossrefPubMedGoogle Scholar
  • 92 Stéphan F, Barrucand B, Petit P. et al; BiPOP Study Group. High-flow nasal oxygen vs noninvasive positive airway pressure in hypoxemic patients after cardiothoracic surgery: a randomized clinical trial. JAMA 2015; 313 (23) 2331-2339
    CrossrefPubMedGoogle Scholar
  • 93 Aigner C, Jaksch P, Taghavi S. et al. Pulmonary retransplantation: is it worth the effort? A long-term analysis of 46 cases. J Heart Lung Transplant 2008; 27 (01) 60-65
    CrossrefPubMedGoogle Scholar
  • 94 Fishman JA. Infection in organ transplantation. Am J Transplant 2017; 17 (04) 856-879
    CrossrefPubMedGoogle Scholar
  • 95 Martinez-Garcia MA, Faner R, Oscullo G. et al. Inhaled steroids, circulating eosinophils, chronic airway infection, and pneumonia risk in chronic obstructive pulmonary disease. A network analysis. Am J Respir Crit Care Med 2020; 201 (09) 1078-1085
    CrossrefPubMedGoogle Scholar
  • 96 Tanaka S, Geneve C, Tebano G. et al. Morbidity and mortality related to pneumonia and TRACHEOBRONCHITIS in ICU after lung transplantation. BMC Pulm Med 2018; 18 (01) 43
    CrossrefPubMedGoogle Scholar
  • 97 Aguilar-Guisado M, Givaldá J, Ussetti P. et al; RESITRA Cohort. Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study. Am J Transplant 2007; 7 (08) 1989-1996
    CrossrefPubMedGoogle Scholar
  • 98 Hadjiliadis D, Steele MP, Chaparro C. et al. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria. J Heart Lung Transplant 2007; 26 (08) 834-838
    CrossrefPubMedGoogle Scholar
  • 99 Fishman JA, Gans H. AST Infectious Diseases Community of Practice. Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33 (09) e13587
    CrossrefPubMedGoogle Scholar
  • 100 Mattner F, Fischer S, Weissbrodt H. et al. Post-operative nosocomial infections after lung and heart transplantation. J Heart Lung Transplant 2007; 26 (03) 241-249
    CrossrefPubMedGoogle Scholar
  • 101 Abbo LM, Grossi PA. AST ID Community of Practice. Surgical site infections: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33 (09) e13589
    PubMedGoogle Scholar
  • 102 Okamoto K, Santos CAQ. Management and prophylaxis of bacterial and mycobacterial infections among lung transplant recipients. Ann Transl Med 2020; 8 (06) 413
    CrossrefPubMedGoogle Scholar
  • 103 Crespo MM, McCarthy DP, Hopkins PM. et al. ISHLT Consensus Statement on adult and pediatric airway complications after lung transplantation: definitions, grading system, and therapeutics. J Heart Lung Transplant 2018; 37 (05) 548-563
    CrossrefPubMedGoogle Scholar
  • 104 Murthy SC, Blackstone EH, Gildea TR. et al; Members of Cleveland Clinic's Pulmonary Transplant Team. Impact of anastomotic airway complications after lung transplantation. Ann Thorac Surg 2007; 84 (02) 401-409 , 409.e1–409.e4
    CrossrefPubMedGoogle Scholar
  • 105 Gottlieb J, Fuehner T, Dierich M, Wiesner O, Simon AR, Welte T. Are metallic stents really safe? A long-term analysis in lung transplant recipients. Eur Respir J 2009; 34 (06) 1417-1422
    Google Scholar
  • 106 Fuehner T, Suhling H, Greer M. et al. Biodegradable stents after lung transplantation. Transpl Int 2013; 26 (07) e58-e60
    CrossrefPubMedGoogle Scholar
  • 107 Shofer SL, Wahidi MM, Davis WA. et al. Significance of and risk factors for the development of central airway stenosis after lung transplantation. Am J Transplant 2013; 13 (02) 383-389
    CrossrefPubMedGoogle Scholar
  • 108 Nguyen AP, Gabriel RA, Golts E, Kistler EB, Schmidt U. Severity of acute kidney injury in the post-lung transplant patient is associated with higher healthcare resources and cost. J Cardiothorac Vasc Anesth 2017; 31 (04) 1361-1369
    CrossrefPubMedGoogle Scholar
  • 109 Kielstein JT, Heiden AM, Beutel G. et al. Renal function and survival in 200 patients undergoing ECMO therapy. Nephrol Dial Transplant 2013; 28 (01) 86-90
    CrossrefPubMedGoogle Scholar
  • 110 Spruit MA, Singh SJ, Garvey C. et al; ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188 (08) e13-e64
    CrossrefPubMedGoogle Scholar
  • 111 Williams TJ, Patterson GA, McClean PA, Zamel N, Maurer JR. Maximal exercise testing in single and double lung transplant recipients. Am Rev Respir Dis 1992; 145 (01) 101-105
    CrossrefPubMedGoogle Scholar
  • 112 Schneeberger T, Gloeckl R, Welte T, Kenn K. Pulmonary rehabilitation outcomes after single or double lung transplantation in patients with chronic obstructive pulmonary disease or interstitial lung disease. Respiration 2017; 94 (02) 178-185
    CrossrefPubMedGoogle Scholar
  • 113 Andrianopoulos V, Gloeckl R, Boensch M. et al. Improvements in functional and cognitive status following short-term pulmonary rehabilitation in COPD lung transplant recipients: a pilot study. ERJ Open Res 2019; 5 (03) 00060-2019
    CrossrefPubMedGoogle Scholar
  • 114 Fuller LM, Button B, Tarrant B. et al. Longer versus shorter duration of supervised rehabilitation after lung transplantation: a randomized trial. Arch Phys Med Rehabil 2017; 98 (02) 220-226.e3
    CrossrefPubMedGoogle Scholar
  • 115 Bertram A, Fuge J, Suhling H. et al. Adherence is associated with a favorable outcome after lung transplantation. PLoS One 2019; 14 (12) e0226167
    CrossrefPubMedGoogle Scholar
  • 116 Corbett C, Armstrong MJ, Neuberger J. Tobacco smoking and solid organ transplantation. Transplantation 2012; 94 (10) 979-987
    CrossrefPubMedGoogle Scholar
  • 117 Bauldoff GS, Holloman CH, Carter S, Pope-Harman AL, Nunley DR. Cigarette smoking following lung transplantation: effects on allograft function and recipient functional performance. J Cardiopulm Rehabil Prev 2015; 35 (02) 147-153
    CrossrefPubMedGoogle Scholar
  • 118 Wan F, Dai H, Zhang S, Moore Y, Wan N, Dai Z. Cigarette smoke exposure hinders long-term allograft survival by suppressing indoleamine 2, 3-dioxygenase expression. Am J Transplant 2012; 12 (03) 610-619
    CrossrefPubMedGoogle Scholar
  • 119 Rea JB, Reidy MF. 218: If there is smoke is there fire? Smoking recidivism after lung transplant. J Heart Lung Transplant 2006; 25 (02) S119-S20
    CrossrefPubMedGoogle Scholar
  • 120 Hofmann P, Kohler M, Benden C, Schuurmans MM. Tobacco use after lung transplantation: a retrospective analysis of patient characteristics, smoking cessation interventions, and cessation success rates. Transplantation 2019; 103 (06) 1260-1266
    CrossrefPubMedGoogle Scholar
  • 121 Ruttens D, Verleden SE, Goeminne PC. et al. Smoking resumption after lung transplantation: standardised screening and importance for long-term outcome. Eur Respir J 2014; 43 (01) 300-303
    CrossrefPubMedGoogle Scholar
  • 122 Strassmann R, Bausch B, Spaar A, Kleijnen J, Braendli O, Puhan MA. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. Eur Respir J 2009; 34 (03) 634-640
    CrossrefPubMedGoogle Scholar
  • 123 Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends--an update. Cancer Epidemiol Biomarkers Prev 2016; 25 (01) 16-27
    CrossrefPubMedGoogle Scholar
  • 124 Sampaio MS, Cho YW, Qazi Y, Bunnapradist S, Hutchinson IV, Shah T. Posttransplant malignancies in solid organ adult recipients: an analysis of the U.S. National Transplant Database. Transplantation 2012; 94 (10) 990-998
    CrossrefPubMedGoogle Scholar
  • 125 Bellil Y, Edelman MJ. Bronchogenic carcinoma in solid organ transplant recipients. Curr Treat Options Oncol 2006; 7 (01) 77-81
    CrossrefPubMedGoogle Scholar
  • 126 de Perrot M, Wigle DA, Pierre AF. et al. Bronchogenic carcinoma after solid organ transplantation. Ann Thorac Surg 2003; 75 (02) 367-371
    CrossrefPubMedGoogle Scholar
  • 127 Van Raemdonck D, Vos R, Yserbyt J, Decaluwe H, De Leyn P, Verleden GM. Lung cancer: a rare indication for, but frequent complication after lung transplantation. J Thorac Dis 2016; 8 (Suppl. 11) S915-S924
    CrossrefPubMedGoogle Scholar
  • 128 Olland AB, Falcoz PE, Santelmo N, Kessler R, Massard G. Primary lung cancer in lung transplant recipients. Ann Thorac Surg 2014; 98 (01) 362-371
    CrossrefPubMedGoogle Scholar
  • 129 Snyder ME, Finlayson MO, Connors TJ. et al. Generation and persistence of human tissue-resident memory T cells in lung transplantation. Sci Immunol 2019; 4 (33) eaav5581
    CrossrefPubMedGoogle Scholar
  • 130 Picard C, Grenet D, Copie-Bergman C. et al. Small-cell lung carcinoma of recipient origin after bilateral lung transplantation for cystic fibrosis. J Heart Lung Transplant 2006; 25 (08) 981-984
    CrossrefPubMedGoogle Scholar
  • 131 Naka M, Shuto S, Konishi C, Maekawa K. High prevalence of airway obstruction and pulmonary emphysema in urothelial (renal pelvis, ureter, and bladder) cancer patients. Respir Investig 2020; 58 (04) 239-245
    CrossrefPubMedGoogle Scholar
  • 132 Kornum JB, Sværke C, Thomsen RW, Lange P, Sørensen HT. Chronic obstructive pulmonary disease and cancer risk: a Danish nationwide cohort study. Respir Med 2012; 106 (06) 845-852
    CrossrefPubMedGoogle Scholar